from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0048c/-

LFCtreatmentdescriptionclass of inhibitor

-1.150

Amikacinug/mL Amikacintranslation

-0.430

Cap5-10ug/mL Capreomycintranslation

-0.178

Rox10-50 ug/mL Roxithromycintranslation

-0.629

SM2-5 ug/mL Streptomycintranslation

-2.290

Tet5-10 ug/mL Tetracyclinetranslation

0.517

Rif0.2-5ug/mL Rifampicintranscription

-0.511

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.773

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.631

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.124

CPZ10-50 ug/mL Chlorpromazinerespiration

1.183

Clofazimine10-13 ug/mL Clofaziminerespiration

0.240

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.778

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.330

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.787

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.588

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.257

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.193

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.565

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.980

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.280

KCN5-20 ug/mL Potassium cyaniderespiration

-0.135

NaN30.2-2 mM Sodium aziderespiration

0.627

Nigericin50 uM Nigericinrespiration

1.089

TRC10-150 ug/mL Triclosanrespiration

0.236

TRZ10-25 ug/mL Thioridazinerespiration

-1.931

Valinomycin0.5-10 uM Valinomycinrespiration

1.393

ZnSO42 mM ZnSO4respiration

-0.897

menadione6-10 ug/mL Menadionerespiration

0.173

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.126

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.584

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.580

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.148

NRP_1Non-replicating persistence stage 1dosRassociated

-0.271

Amp0.2mg/mL AmpicillincellWall

-0.059

Cephalexin20-100 ug/mL CephalexincellWall

-0.286

Cerulenin0.32-5 ug/mL CerulenincellWall

0.368

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.008

EMB10-20 ug/mL EthambutolcellWall

-0.562

Eta12-40 ug/mL EthionamidecellWall

-0.780

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.395

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.339

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.234

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.042

BZA0.12 mg/mL BenzamidearomaticAmides

0.035

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.169

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.284

H2O24 mM hydrogen peroxideDNAdamaging

-0.167

Levo10 ug/mL LevofloxacinDNAdamaging

-0.079

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.720

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.141

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.420

UVUV-irradiationDNAdamaging

-0.624

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.277

Antimycin12.5-50 ug/mL Antimycin A?

0.121

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.562

PA_110-50 ug/mL Antitubercular compound PA-1?

0.250

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.197

PA8240.2-2 ug/mL PA-824?

-0.395

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.545

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.498

Verapamil50 uM Verapamil?

0.138

mercaptoethanol2 mM 2-Mercaptoethanol?

0.656

methoxatin10-20 ug/mL Methoxatin?